WI
VRTX icon

WBI Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

WBI Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,114
Closed -$505K – 417
2025
Q4 		$505K Buy
+1,114
New +$480K 0.13% 202
2024
Q1 		– Sell
-662
Closed -$269K – 256
2023
Q4 		$269K Buy
+662
New +$245K 0.05% 179
2023
Q2 		– Sell
-6,414
Closed -$2.02M – 232
2023
Q1 		$2.02M Buy
+6,414
New +$1.92M 0.4% 67

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

WBI Investments's VRTX Position: Q1 2026 in Review

WBI Investments sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 1,114 shares — an estimated $505K sold.

WBI Investments first reported a position in VRTX in Q1 2023 and held it in 3 quarters. The position peaked at $2.02M in Q1 2023. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • WBI Investments reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • WBI Investments sold 1,114 Vertex Pharmaceuticals shares in Q1 2026, an estimated $505K.
  • WBI Investments first reported a position in Vertex Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • WBI Investments's Vertex Pharmaceuticals position peaked at $2.02M in Q1 2023.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.